Patent application number | Description | Published |
20110166880 | Method and System for Analyzing Health Related Data of Patients - System and method for analyzing health related data associated with a patient, comprising: an expert's station; a health database comprising health related data of patients; a wizard application, enabling the expert to create a template of commands for analyzing the health related data of the patient according to the expert's school of method, using a generic model associated with the expert's field of expertise, where the analysis calculates health related profile of the patient; a templates database comprising templates of commands created by experts; a generic models database, enabling the wizard to retrieve and store a generic model associated with the expert's field of expertise; and a main server for using the template of commands to analyze the health data of a patient, according to the analysis method of the expert, by operating the commands in the template for calculating health related profile of the patient. | 07-07-2011 |
20120259657 | Method and System for Analyzing Health Related Data of Patients - System and method for analyzing health related data associated with a patient, comprising: an expert's station; a health database comprising health related data of patients; a wizard application, enabling the expert to create a template of commands for analyzing the health related data of the patient according to the expert's school of method, using a generic model associated with the expert's field of expertise, where the analysis calculates health related profile of the patient; a templates database comprising templates of commands created by experts; a generic models database, enabling the wizard to retrieve and store a generic model associated with the expert's field of expertise; and a main server for using the template of commands to analyze the health data of a patient, according to the analysis method of the expert, by operating the commands in the template for calculating health related profile of the patient. | 10-11-2012 |
Patent application number | Description | Published |
20080197801 | Bidirectional Battery Charge Controller - A bidirectional battery charge control system for a portable electronic device which uses a rechargeable main battery. The system enables the connection of an auxiliary battery to the device for inputting additional current to the device. Control of the current flow into and out of the auxiliary battery is performed by a bidirectional charger. The auxiliary battery can contain one or more readily available primary or secondary cells, and the bidirectional charger is such that an external charger connected to the device, generally used to charge the main rechargeable battery of the device, can also recharge a secondary cell or cells in the auxiliary battery, if such are installed. The use of such an auxiliary battery enables the main battery to be hard-wired into the device. | 08-21-2008 |
20080284370 | Portable Battery Operated Power Supply - A portable battery-powered power supply or charger for use with electronic devices containing a primary or secondary battery. In order to control the current flow into and out of its battery, the portable power supply uses a bidirectional charge controller. The battery is installed in a housing which preferably has a single connector port to which a flexible current lead may be plugged. The bidirectional charge controller enables the battery either to supply current to the electronic device, to charge the device's internal battery, or it allows the battery, if it is a secondary battery, to be charged by connection to an externally powered charger, such as a wall mains adapter. Both of these functions are achieved through a single connection port. | 11-20-2008 |
20100013430 | CHARGING METHODS FOR BATTERY POWERED DEVICES - A battery charge control system including an algorithm for determining whether the battery chemistry of a battery pack for use in a portable electronic device is primary, in which case charging is prevented, or secondary, in which case charging is enabled. The routine operates by measuring the terminal voltage and temperature of the battery under certain predetermined tests, which generally include a combination of voltage and internal impedance tests performed during charge or discharge. Additionally, a method is described to detect and to correct for lack of cell balance within the rechargeable battery pack of a portable electronic device. A cell or cells of the battery pack which are close to depletion, or are completely depleted, are detected, and a discharge/charge routine is executed to provide for optimum recharging of all of the cells of the battery, thus ensuring proper cell balance, and most efficient power usage. | 01-21-2010 |
20110148344 | Battery Powered Charger - A charger for recharging the batteries of a portable electronic device even when no external power source is available. A battery or cell is installed within the charger, and when no access is available to a fixed power source into which the charger can be plugged, the internal battery or cell can be used to recharge the electronic device. The internal battery can be a primary battery or a secondary battery. In the latter case, the internal battery can be maintained in a charged state by means of circuitry which, when the charger is plugged into the external power source, charges the internal battery as well as the battery of the electronic device. The external power source can be either an AC power wall socket, in which case the charger includes AC/DC voltage conversion circuits, or a car lighter socket, or the DC output of a conventional wall charger. | 06-23-2011 |
20110298414 | BIDIRECTIONAL BATTERY CHARGE CONTROLLER - There is disclosed a battery power supply system adapted to be installed in a portable electronic device, and a method of powering a portable electronic device. Other embodiments are also disclosed. | 12-08-2011 |
20130076136 | Battery Powered Charger - A charger for recharging the batteries of a portable electronic device even when no external power source is available. A battery or cell is installed within the charger, and when no access is available to a fixed power source into which the charger can be plugged, the internal battery or cell can be used to recharge the electronic device. The internal battery can be a primary battery or a secondary battery. In the latter case, the internal battery can be maintained in a charged state by means of circuitry which, when the charger is plugged into the external power source, charges the internal battery as well as the battery of the electronic device. The external power source can be either an AC power wall socket, in which case the charger includes AC/DC voltage conversion circuits, or a car lighter socket, or the DC output of a conventional wall charger. | 03-28-2013 |
Patent application number | Description | Published |
20080272962 | WIRELESS AREA NETWORK COMPLIANT SYSTEM AND METHOD USING A PHASE ARRAY ANTENNA - A wireless area network communication system comprising at least one phased array antenna frame, a phased array antenna circuit connected to the at least one phased array antenna frame wherein said phased array circuit and said at least one phased array antenna frame are adapted to transmit and receive wireless area network compliant signals from or to wireless area network devices. | 11-06-2008 |
20100052975 | COMPACT ACTIVE PHASED ARRAY ANTENNA FOR RADARS - A radar system, including: a compact, active phased array antenna for transmission and reception of a focused radiation beam, circuits for providing signals to produce or detect a radiation beam by the phased array antenna and to control or detect the direction of the radiation beam, and wherein the radar is adapted to be mounted on a missile and scan a selected area proceeding the direction of motion of the missile. | 03-04-2010 |
20100188289 | COMMUNICATION SYSTEM AND METHOD USING AN ACTIVE PHASED ARRAY ANTENNA - The subject matter discloses a wireless communication system comprising: at least one active phased array antenna unit for transmission and reception of electronic radiation and a phased array circuit for driving and controlling said at least one phased array antenna unit, wherein said at least one phased array antenna unit comprises at least four one dimensional arrays of radiations. The subject matter also discloses a method for utilizing the described system. | 07-29-2010 |
20110100076 | APPARATUS AND METHOD FOR ELECTRONIC LOCK KEY INDICATOR - An apparatus for tracking and indicating the status of a lock, comprising: a movement sensing device for sensing movement of a key related to said lock and providing information about said movement; a controller for reception of said information about said movement, processing said information and identifying a key rotation event that is associated with a lock status; and an indication unit being connected to said controller; providing an indication of the lock status according to control signals that are provided by said controller. | 05-05-2011 |
20110285528 | WIRELESS NETWORK APPARATUS AND METHOD FOR LOCK INDICATION - An apparatus for tracking the status of a lock, comprising: at least one lock tracking device for tracking a status of a lock; and at least one wireless key unit; wherein each of said at least one wireless key unit is connected to one of said at least one lock tracking device, and wherein said at least one wireless key unit includes a transceiver unit for transmitting information obtained from the at least one lock tracking device regarding the status of the lock. | 11-24-2011 |
20120207265 | APPARATUS AND METHOD FOR ELECTRONIC DETECTION OF KEY INSERTION - An apparatus for detecting a key insertion into a lock or a key removal from the lock, comprising: a movement sensing device attached to the key configured to sense movement of the key; and a processing unit configured to process signals received from said movement sensing device, the processing unit is configured to detect a key insertion into a lock, or a key removal from a lock based on the signals received from said movement sensing device. | 08-16-2012 |
Patent application number | Description | Published |
20100105627 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 04-29-2010 |
20120009229 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 01-12-2012 |
20120093886 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 04-19-2012 |
20150031631 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY - The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed. | 01-29-2015 |
Patent application number | Description | Published |
20090299175 | LOCATION TRACKING OF A METALLIC OBJECT IN A LIVING BODY - A method and apparatus are provided for determining and tracking location of a metallic object in a living body, and then directing a second modality such as ultrasound waves to the determined location. The metal detector may be a radar detector adapted to operate on a living body. The adaption may include disposing a transfer material having electromagnetic properties similar to the body between the radar detector and the living body, ECG gating the radar detector, and/or employing an optimal estimator with a model of expected stent movement in a living body. Applications include determination of extent of in-stent restenosis, performing therapeutic thrombolysis, or determining operational features of a metallic implant. | 12-03-2009 |
20130123614 | Location Tracking of a Metallic Ojbect in a Living Body - A method and apparatus are provided for determining and tracking location of a metallic object in a living body, and then directing a second modality such as ultrasound waves to the determined location. The metal detector may be a radar detector adapted to operate on a living body. The adaption may include disposing a transfer material having electromagnetic properties similar to the body between the radar detector and the living body, ECG gating the radar detector, and/or employing an optimal estimator with a model of expected stent movement in a living body. Applications include determination of extent of in-stent restenosis, performing therapeutic thrombolysis, or determining operational features of a metallic implant. | 05-16-2013 |
20130190646 | Implantable Dielectrometer - Diagnostic apparatus ( | 07-25-2013 |
20130231550 | Implantable Radio-Frequency Sensor - Diagnostic apparatus ( | 09-05-2013 |
20150025333 | MONITORING AND DIAGNOSTIC SYSTEMS AND METHODS - An apparatus, a system, and a method for monitoring and/or performing a diagnosis. A first implantable device measures a property of a first tissue in a body and includes a housing. The housing includes a first processing circuitry for causing the first implantable device to measure the property of the first tissue. A second implantable device for measures a property of a second tissue in the body and includes a housing. The housing includes a second processing circuitry for causing the second implantable device to measure the property of the second tissue using at least one sensor. The second implantable device is communicatively coupled to the first implantable device and provides information about the measured property of the second tissue to at least one of the following: the first implantable device and at least one processing device disposed externally to the body. | 01-22-2015 |
Patent application number | Description | Published |
20080287366 | Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus - The subject invention provides a pharmaceutical composition comprising an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a peptide having the structural formula | 11-20-2008 |
20090169559 | Parenteral formulations of peptides for the treatment of systemic lupus erythematosus - The subject invention provides a pharmaceutical composition comprising: an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of the composition of a pharmaceutically acceptable salt of a) a peptide comprising at least 12 and at most 30 consecutive amino acids having a sequence corresponding to (i) a sequence of amino acids found within a complementarity-determining region (CDR) of a heavy or a light chain of a human monoclonal anti-DNA 16/6 Id antibody, or (ii) a sequence of amino acids found within a complementarity-determining region (CDR) of a heavy or a light chain of a pathogenic anti-DNA monoclonal antibody that induces a systemic lupus erythematosus (SLE)-like disease response in mice, or b) a peptide comprising consecutive amino acids having the sequence shown by any of SEQ ID NOS. 8-17, or c) a peptide comprising consecutive amino acids having a sequence of any of a) and b), or at least two of the sequences in (a)(i), (a)(ii) and (b)(i) through (b)(x), or d) a peptide comprising consecutive amino acids having a sequence comprising at least two identical sequences included in (a)(i), (a)(ii) and (b)(i) through (b)(x); and a solubility enhancer, wherein both the peptide and the solubility enhancer are dissolved in the aqueous carrier; and wherein the composition has a pH between 4 and 9, and a method of alleviating symptoms of SLE in a human by administering an effective amount of the composition. | 07-02-2009 |
20130023485 | PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS - The subject invention provides a pharmaceutical composition comprising: an aqueous carrier; from 0.1 mg/ml to 20 mg/ml of a pharmaceutically acceptable salt of a) a peptide comprising at least 12 and at most 30 consecutive amino acids, b) a peptide comprising consecutive amino acids having the sequence shown by any of SEQ ID NOS. 8-17, c) a peptide comprising consecutive amino acids having a sequence of any of a) and b), or at least two sequences in (a), or d) a peptide comprising consecutive amino acids having a sequence comprising at least two identical sequences included in (a); and a solubility enhancer; and wherein the composition has a pH between 4 and 9, and a method of alleviating symptoms of SLE in a human by administering an effective amount of the composition. | 01-24-2013 |
Patent application number | Description | Published |
20100028859 | Hyper-Spectral Imaging and Analysis of a Sample of Matter, and Preparing a Test Solution or Suspension Therefrom - Method for hyper-spectral imaging and analysis of a sample of matter, for identifying and characterizing an object of interest therein. Preparing test solution or suspension of the sample, including adding thereto a spectral marker specific to object of interest, such that if object of interest is in test solution or suspension, object of interest becomes a hyper-spectrally active target which is hyper spectrally detectable and identifiable; adding to test solution or suspension a background reducing chemical, for reducing background interfering effects caused by presence of objects of non-interest in test solution or suspension, thereby increasing hyper spectral detectability of hyper spectrally active target in test solution or suspension; generating and collecting hyper-spectral image data and information of test solution or suspension; and, processing and analyzing thereof. Exemplary objects of interest are biological agents—bacteria ( | 02-04-2010 |
20120202192 | HYPER-SPECTRAL IMAGING AND ANALYSIS OF A SAMPLE OF MATTER, FOR IDENTIFYING AND CHARACTERIZING AN OBJECT OF INTEREST THEREIN - Method for hyper-spectral imaging and analysis of a sample of matter, for identifying and characterizing an object of interest therein. Preparing test solution or suspension of the sample, including adding thereto a spectral marker specific to object of interest, such that if object of interest is in test solution or suspension, object of interest becomes a hyper-spectrally active target which is hyper-spectrally detectable and identifiable; adding to test solution or suspension a background reducing chemical, for reducing background interfering effects caused by presence of objects of non-interest in test solution or suspension, thereby increasing hyper-spectral detectability of hyper-spectrally active target in test solution or suspension; generating and collecting hyper-spectral image data and information of test solution or suspension; and, processing and analyzing thereof. Exemplary objects of interest are biological agents—bacteria ( | 08-09-2012 |
Patent application number | Description | Published |
20110200067 | THERMALLY BASED SYSTEM AND METHOD FOR DETECTING COUNTERFEIT DRUGS - The invention relates to a thermal system for determining the authenticity of a pharmaceutical product, said system comprises: (a) a signal generator and heat/cooling source for applying a temperature variation signal to a pharmaceutical product; (b) a thermal apparatus for: (b.1.) following or during an application of said temperature variation signal to an authentic pharmaceutical product, acquiring at predefined controlled conditions an authenticity signature of said authentic product, said authenticity signature comprises at least one temperature measurement of said authentic product, each of said temperature measurements describes the reaction over time of the authentic product to said temperature variation signal; (b.2.) storing said acquired authenticity signature in a memory; and (b.3) for a tested pharmaceutical product that corresponds to said authentic product, and whose authenticity is suspected, and following or during an application of same temperature variation signal to said tested product, acquiring at same predefined controlled conditions a test signature, said test signature also comprises at least one temperature measurement of said tested product, each of said latter temperature measurements describes the reaction over time of the tested product to said temperature variation signal; and (c) a comparison unit for comparing between said authenticity signature and said test signature. | 08-18-2011 |
20110293166 | METHOD AND SYSTEM FOR DETERMINING THE QUALITY OF PHARMACEUTIAL PRODUCTS - Thermographic imaging is used to monitor quality parameters of pharmaceutical products ( | 12-01-2011 |
20120012750 | THERMOGRAPHY BASED SYSTEM AND METHOD FOR DETECTING COUNTERFEIT DRUGS - The invention relates to a thermography IR system for determining the authenticity of a pharmaceutical product, the system comprises: (a) a thermography IR apparatus for: (a.1) acquiring at predefined controlled conditions an authenticity signature of an authentic pharmaceutical product, said authenticity signature comprises at least one thermography image of said authentic product, each of said images describes the distribution over said product of the IR radiation in an MWIR or LWIR spectrum as a function of temperature and emissivity; (a.2) storing said acquired authenticity signature in a memory; and (a.3) for a tested pharmaceutical product that corresponds to said authentic product, and whose authenticity is suspected, acquiring at same predefined controlled conditions a test signature, said test signature also comprises at least one thermography image of said tested product, each of said images describes the distribution over said test product of the IR radiation in an MWIR or LWIR spectrum as a function of temperature and emissivity; and (b) a comparison unit for comparing between said authenticity signature and said test signature. | 01-19-2012 |
20140252237 | METHODS OF DETECTING THE PRESENCE OF MICROORGANISMS IN A SAMPLE - The present disclosure provides a method of detecting the presence of a microorganism in a tested sample, the method comprises:
| 09-11-2014 |